The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 15, 2018

Filed:

Dec. 10, 2013
Applicant:

Lion Corporation, Sumida-ku, JP;

Inventors:

Chiyoko Uchiyama, Tokyo, JP;

Kei Kurita, Tokyo, JP;

Assignee:

LION CORPORATION, Sumida-ku, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); C07K 14/47 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); C07K 14/47 (2013.01); G01N 33/68 (2013.01); G01N 2333/47 (2013.01); G01N 2333/8139 (2013.01); G01N 2800/042 (2013.01); G01N 2800/50 (2013.01);
Abstract

The object of the present invention is to provide a marker substance capable of determining a risk of hyperglycemia in vivo with high accuracy. The present invention provides the following: a marker peptide for determining the risk of hyperglycemia; an antibody or an aptamer bound to the marker peptide for determining the risk of hyperglycemia; a microarray wherein the antibody or the aptamer to be bound to the marker peptide for determining the risk of hyperglycemia has been immobilized onto a carrier; a method of determining the risk of hyperglycemia wherein an amount or the presence/absence of the marker peptide for determining the risk of hyperglycemia is measured in a biological sample collected from a subject; and a kit for determining the risk of hyperglycemia comprising the antibody or the aptamer, or the microarray.


Find Patent Forward Citations

Loading…